Acadia’s pimavanserin improves schizophrenia symptoms in trial

Schizophrenia is a chronic, debilitating mental disorder characterised by positive and negative symptoms. Credit: Gerd Altmann from Pixabay.



  • Acadia’s pimavanserin improves schizophrenia symptoms in trial patients